Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 92,271

Document Document Title
WO/2021/092060A1
The disclosure relates to multispecific antibodies against BCMA for use in the treatment of lymphoma, such as non-Hodgkin's Lymphoma (NHL).  
WO/2021/092090A1
Disclosed herein are methods for palmar or plantar administration of anticholinergic compounds to a subject in need thereof. Also disclosed herein are methods of treating palmar or plantar hyperhidrosis in a subject in need thereof by ad...  
WO/2021/092382A1
A method of treating or preventing a microbial infection in a patient is provided, along with a wound irrigation system and a composition in the form of an irrigation liquid for reducing microbial load or preventing microbial infection i...  
WO/2021/091304A1
The present invention relates to a novel human epidermal growth factor (hEGF)-trigger factor (TF) fusion protein and a use thereof. More particularly, the human epidermal growth factor (hEGF)-trigger factor (TF) fusion protein of the pre...  
WO/2021/092050A1
The present disclosure provides, inter alia, treating and/or preventing skin diseases and disorders and symptoms thereof, using recombinant LEKTI domains and microbes genetically modified to express one or more LEKTI protein domains enco...  
WO/2021/092240A1
The present disclosure is directed to use of MrgprX2 antagonists in the treatment of inflammatory disorders, e.g., inflammatory disorders of the skin. This invention is also directed to pharmaceutical compositions comprising a MrgprX2 an...  
WO/2021/091502A1
The invention is related to a method for producing a product suitable for use in the treatment of hair loss and scar by means of applying on the skin locally or subdermal injection; comprising process steps of; collecting amniotic fluids...  
WO/2021/090322A1
The present invention, in some embodiments, relates to a method of treatment, prevention or alleviation of Palmoplantar Keratoderma (PPK) in a patient in need thereof, comprising a debridement step followed by topical administration of a...  
WO/2021/092262A1
The present disclosure is directed to use of MrgprX2 antagonists in the treatment of inflammatory disorders, e.g., inflammatory disorders of the skin. This invention is also directed to pharmaceutical compositions comprising a MrgprX2 an...  
WO/2021/091080A1
The present invention relates to a composition for preventing or treating hair loss, or promoting hair growth or hair thickening, comprising a complex extract of beet, red onion and purple-fleshed sweet potato as an active ingredient. Th...  
WO/2021/091846A1
The present disclosure relates to the use of Compound (I) or a pharmaceutically acceptable salt thereof, for the treatment of mast cell diseases and eosinophilic disorders.  
WO/2021/092239A1
This disclosure is directed to use of IRAK4 inhibitors in the treatment of dermatological disorders or conditions characterized by inflammation. This disclosure is also directed to pharmaceutical compositions comprising an IRAK4 inhibito...  
WO/2021/087561A1
The invention provides fusion proteins comprising a growth factor or cytokine and a syndecan binding peptide and the use of such fusion proteins in regenerative medicine, particularly in treating skin wounds, including diabetic wounds an...  
WO/2021/091356A1
The present invention relates to a pharmaceutical composition, a functional food composition, and a cosmetic composition which include methyl benzoate or a derivative thereof as an active ingredient, and are for preventing or treating st...  
WO/2021/091310A1
The present invention relates to a novel human epidermal growth factor (hEGF) fusion protein and a use thereof. More specifically, the hEGF fusion protein of the present invention comprises: a Bacillus subtilis CH2-derived chitosanase si...  
WO/2021/089820A1
The present invention relates to a fistula filling device comprising: • - a biocompatible material in the form of a tab (1) having a proximal end (2) and a distal end (3); • - a biological material in the form of a moulded ground mat...  
WO/2021/084791A1
The purpose of the invention is to identify a new receptor participating in the differentiation of helper T cells and to develop a drug targeted thereto. It has been discovered that an adenosine A2A receptor participates in control of th...  
WO/2021/084213A1
The present invention relates to the use of neurosporene to protect the skin from the harmful effects of blue light and/or UVA, to promote epidermal regeneration or renewal, and to stimulate wound healing.  
WO/2021/085496A1
Disclosed are an antioxidant agent, an antisaccharification agent, a neurite outgrowth promoter, and a cognitive function improver which contain propolis and gingko leaf extract as active ingredients.  
WO/2021/084541A1
Disclosed are topical compositions and methods of treatment of hair loss by topical administration to a subject in need thereof of a composition comprising a therapeutically effective amount of at least one EGFR inhibitor and optionally ...  
WO/2021/087314A1
A medicinal, cosmetic or dermatologic product is described made from a reconstituted cannabis material. The reconstituted cannabis material forms a sheet-like layer that can be shape configured to cover a portion of a user's body. The pr...  
WO/2021/086698A1
The reduction in the sol-gel temperature of aqueous poloxamer surfactant compositions by the addition of hydrophobic vicinal diols is provided. Lowering of the sol-gel temperature and the gelling efficiency of water-soluble poloxamer blo...  
WO/2021/085633A1
[Problem] To improve permeability of skin external agents such as cosmetics into the skin. [Solution] When applying, to the skin, a skin external agent that contains a specific component to be applied to the skin of a right hand (1R), fo...  
WO/2021/083920A1
The invention relates to a cosmetic or dermatological composition containing: at least one prebiotically active bacteria strain which has a positive influence on skin health when settling on the skin; a protector strain of the genus Lact...  
WO/2021/021593A8
The invention provides methods of preventing or treating hair loss by adoptive transfer of plasmacytoid dendritic cells and related compositions.  
WO/2021/086120A1
The present invention relates to a composition, comprising a Salvia miltiorrhiza Bunge extract as an active ingredient, for treatment or prevention of benign prostatic hyperplasia or alopecia. The Salvia miltiorrhiza Bunge extract compri...  
WO/2021/085295A1
The present invention addresses the problem of clarifying the immune response mechanism of IL-17-producing cells, said immune response mechanism inducing pathological conditions such as psoriasis, to thereby provide an immune response su...  
WO/2021/083766A1
The present invention relates to compositions, immunogenic or vaccine compositions and pharmaceutical compositions for the prevention or treatment of a condition or disorder selected from a pruritic condition or an allergic condition, of...  
WO/2021/081642A1
The present disclosure relates to methods of ameliorating an inflamed state in a cell or tissue by subjecting an inflamed cell or tissue to a biophotonic composition, illuminating the biophotonic composition for a time sufficient for the...  
WO/2021/087415A1
A method of treating or preventing P. acnes and/or S. aureus infection is described, involving contacting P. acnes and/or S. aureus, or a physiological locus infected or susceptible to infection by P. acnes and/or S. aureus, with at leas...  
WO/2021/087239A1
The present invention relates to a method for treating skin, comprising the following step A) and then step B): A) physically or chemically treating an epidermis of the skin; and B) forming a film containing a fiber deposit on the skin w...  
WO/2021/084229A1
A transdermal patch is provided, wherein the patch comprises a cross-linked poly(ethylene oxide) hydrogel loaded with naltrexone, or a pharmaceutically acceptable salt or solvate thereof, and an occlusive adhesive tape. The poly(ethylene...  
WO/2021/087051A1
The invention is directed to a topical composition comprising one or more topical active ingredients selected from the group consisting of benzoyl peroxide, azelaic acid, dapsone, resorcinol, erythromycin and clindamycin, one or more non...  
WO/2021/084760A1
In conventional evaluation methods or screening methods for PAR-2 inhibitory effects, the activation of PAR-2 is indirectly evaluated by using, as an index, intracellular reactions occurring in PAR-2-expressing cultured cells after the P...  
WO/2021/083912A1
The present invention relates to novel uses of nitazoxanide, or analogues thereof.  
WO/2021/083919A1
The invention relates to a cosmetic or dermatological composition containing: at least one prebiotically active bacteria strain which has a positive influence on skin health when settling on the skin; and licochalcone A. The invention fu...  
WO/2021/078022A1
Provided in the present invention is a small molecule compound, which is characterized in that it is a compound or a stereoisomer, geometric isomer, tautomer, racemate, hydrate, solvate, metabolite, and pharmaceutically acceptable salt o...  
WO/2021/081345A1
The present invention includes a bi-peptide, a method of making, and a method using the bi-peptide to treat a disease or condition, wherein the bi-peptide comprises the formula: peptide 1n - linkern - peptide 2n, or peptide 2n - linkern ...  
WO/2021/080500A1
The invention relates a pharmaceutical composition comprising from 0.001 to 2 % (w/v) of propane-1,2- diol as the only anti-inflammatory agent and at least one bioadhesive polymer. The pharmaceutical composition can be used in ameliorati...  
WO/2021/079536A1
This composition for lysis of Staphylococcus aureus or this composition for prevention or therapy of diseases caused by Staphylococcus aureus contains as active ingredients: at least one bacteriophage selected from the group consisting o...  
WO/2021/055577A3
The invention provides anti-KLK7 antibodies, anti-KLK5 antibodies, anti-KLK5/KLK7 multispecific antibodies, and methods of using the same.  
WO/2021/078937A1
The present invention relates to a pharmaceutically compatible iron chelator or prodrug thereof for use in treating and/or preventing a disease caused or aggravated by STAT3 hyperactivity in effector cells in a subject; and to methods, k...  
WO/2021/078023A1
Provided is a small molecule compound, which is characterized in having the structure represented by the following molecular formula: (I), wherein X1 and X2 are selected from carbon or nitrogen; G1 is a carbocyclic ring or heterocyclic r...  
WO/2021/080527A1
The present invention relates to a topical pharmaceutical spray compositions comprising difluocortolone valerate, isoconazole nitrate, ethanol and propylene glycol, the process for preparing the compositions and uses thereof. The weight ...  
WO/2021/079986A1
A composition for lysing Staphylococcus aureus or a composition for preventing or treating a disease caused by Staphylococcus aureus, said composition comprising, as active ingredients, at least one bacteriophage selected from the group ...  
WO/2021/078021A1
Provided in the present invention is a small molecular compound, which is characterized in being a compound represented by the following structural formula or a stereoisomer, geometric isomer, tautomer, racemate, hydrate, solvate or meta...  
WO/2021/079435A1
This composition is for lysing Staphylococcus aureus or treating or preventing diseases caused by Staphylococcus aureus, and contains, as active ingredients, at least one bacteriophage selected from the group consisting of the bacterioph...  
WO/2021/080129A1
The present invention relates to a composition for strengthening the skin barrier and alleviating atopic dermatitis, having hydrangenol or phyllodulcin as an active ingredient. The composition having hydrangenol or phyllodulcin or a phar...  
WO/2021/079798A1
The present invention is a wipe material which comprises a nonwoven fabric and an aqueous composition that is supported by the nonwoven fabric, wherein: the aqueous composition contains (a) a cationic surfactant, (b) an inorganic salt th...  
WO/2021/080648A1
Silicon-based cannabidiol derivatives and methods for their synthesis are provided, in which the derivatives contain a cannabidiol molecule and at least one silicon-based group containing Si-O-Si bonds. The derivatives are useful in cosm...  

Matches 1 - 50 out of 92,271